Validación de una terapia celular bifuncional para mejorar el pronóstico de tumores cerebrales pediátricos tras la radioterapia

Descripción

The project focuses on the validation of a bifunctional cell therapy combining mesenchymal stem cells (MSCs) and melatonin to improve outcomes in pediatric brain tumors after radiotherapy. It evaluates how this approach can enhance post-radiotherapy prognosis by targeting tumor progression and radiation-induced damage, aiming to improve therapeutic efficacy and long-term outcomes in childhood brain cancer.

Investigadores/as del proyecto

• Vivian Capilla González – Investigador/a Principal

Entidades financiadoras

Instituto de Salud Carlos III